請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/43045完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 王錦堂 | |
| dc.contributor.author | Wei-Ching Lee | en |
| dc.contributor.author | 李韋慶 | zh_TW |
| dc.date.accessioned | 2021-06-15T01:34:18Z | - |
| dc.date.available | 2014-09-15 | |
| dc.date.copyright | 2009-09-15 | |
| dc.date.issued | 2009 | |
| dc.date.submitted | 2009-07-18 | |
| dc.identifier.citation | 1. Podschun R and Ullmann U., Klebsiella spp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors. Clin. Microbiol. Rev., 1998. 11(4): p. 589-603.
2. Sahly H. and Podschun R., Clinical, bacteriological, and serological aspects of Klebsiella infections and their spondylarthropathic sequelae. Clin. Diagn. Lab. Immunol., 1997. 4(4): p. 393-399. 3. Wang JH, Liu YC, Lee SS, Yen MY, Chen YS, Wang JH, Wann SR, and Lin HH., Primary Liver Abscess Due to Klebsiella pneumoniae in Taiwan. Clin. Infect. Dis., 1998. 26(6): p. 1434-1438. 4. Fang CT, Chang SC, Hsueh PR, Chen YC, Sau WY, and Luh KT., Microbiologic features of adult community-acquired bacterial meningitis in Taiwan J Formos Med Assoc., 2000. 99(4): p. 300~304. 5. Liu YC, Cheng DL and Lin CL., Klebsiella pneumoniae Liver Abscess Associated With Septic Endophthalmitis. Arch Intern Med, 1986. 146(10): p. 1913-1916. 6. Fung CP, Chang FY, Lee SC, Hu BS, Kuo BI, Liu CY, Ho M, and Siu LK., A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut, 2002. 50(3): p. 420-424. 7. Cheng DL, Liu YC, Yen MY, Liu CY, and Wang RS., Septic metastatic lesions of pyogenic liver abscess : their association with Klebsiella pneumoniae bacteremia in diabetic patients. Arch Intern Med, 1991. 151: p. 1557-1559. 8. Chiu CT, Lin DY, and Liaw YF., Metastatic Septic Endophthalmitis in Pyogenic Liver Abscess. J Clin Gastroenterol, 1988. 10(5): p. 524-527. 9. Fang CT, Chuang YP, Shun CT, Chang SC, and Wang JT., A Novel Virulence Gene in Klebsiella pneumoniae Strains Causing Primary Liver Abscess and Septic Metastatic Complications. J. Exp. Med., 2004. 199(5): p. 697-705. 10. Chuang YP, Fang CT, Lai SY, Chang SC, and Wang JT., Genetic Determinants of Capsular Serotype K1 of Klebsiella pneumoniae Causing Primary Pyogenic Liver Abscess. J Infect Dis, 2006. 193(5): p. 645-654. 11. Pan YJ, Fang HC, Yang HC, Lin TL, Hsieh PF, Tsai FC, Keynan Y, and Wang JT., Capsular polysaccharide synthesis regions in Klebsiella pneumoniae serotype K57 and a new capsular serotype. J Clin Microbiol., 2008. 46(7): p. 2231-2240. 12. Fang CT, Lai SY, Yi WC, Hsueh PR, Liu KL, and Chang SC., Klebsiella pneumoniae Genotype K1: An Emerging Pathogen That Causes Septic Ocular or Central Nervous System Complications from Pyogenic Liver Abscess. Clin. Infect. Dis., 2007. 45(3): p. 284-293. 13. Wacharotayankun R, Arakawa Y, Ohta M, Tanaka K, Akashi T, Mori M, and Kato N., Enhancement of extracapsular polysaccharide synthesis in Klebsiella pneumoniae by RmpA2, which shows homology to NtrC and FixJ. Infect. Immun., 1993. 61(8): p. 3164-3174. 14. Zamze S, Martinez-Pomares L, Jones H, Taylor PR, Stillion RJ, Gordon S, and Wong SY., Recognition of Bacterial Capsular Polysaccharides and Lipopolysaccharides by the Macrophage Mannose Receptor. J. Biol. Chem., 2002. 277(44): p. 41613-41623. 15. Lu CH, Chang WN, Chuang YC, and Chang HW., The prognostic factors of adult Gram-negative bacillary meningitis. J Hosp Infect, 1998. 40(1): p. 27-34. 16. Jang TN, Wang FD, Wang LS, Yu KW, and Liu CY, Gram-negative bacillary meningitis in adults: a recent six-year experience. J Formos Med Assoc. , 1993. 92(6): p. 540-6. 17. Fang CT, Chen YC, Chang SC, Sau WY, and Luh KT., Klebsiella pneumoniae meningitis: timing of antimicrobial therapy and prognosis. QJM, 2000. 93(1): p. 45-53. 18. Ko WC, Paterson DL, Sagnimeni AJ, Hansen DS, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, McCormack JG, and Yu VL., Community-Acquired Klebsiella pneumoniae Bacteremia: Global Differences in Clinical Patterns. Emerg Infect Dis, 2002. 8(2): p. 160-166. 19. Ma LC, Fang CT, Lee CZ, Shun CT, and Wang JT., Genomic Heterogeneity in Klebsiella pneumoniae Strains Is Associated with Primary Pyogenic Liver Abscess and Metastatic Infection. J Infect Dis, 2005. 192(1): p. 117-128. 20. Hsieh PF, Lin TL, Lee CZ, Tsai SF, and Wang JT., Serum-induced iron-acquisition systems and TonB contribute to virulence in Klebsiella pneumoniae causing primary pyogenic liver abscess. J Infect Dis, 2008. 197(12): p. 1717-1727. 21. Salehen N and Stover C., The role of complement in the success of vaccination with conjugated vs. unconjugated polysaccharide antigen. Vaccine, 2008. 26(4): p. 451-459. 22. Pletz MW, Maus U, Hohlfeld JM, Lode H, and Welte T., Pneumococcal vaccination: conjugated vaccine induces herd immunity and reduces antibiotic resistance. Dtsch med Wochenschr, 2008. 133(8): p. 358-62. 23. Fattom A, Schneerson R, Szu SC, Vann WF, Shiloach J, Karakawa WW, and Robbins JB., Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A. Infect. Immun., 1990. 58(7): p. 2367–2374. 24. Monteiro MA, Baqar S, Hall ER, Chen YH, Porter CK, Bentzel DE, Applebee L, and Guerry P., Capsule Polysaccharide Conjugate Vaccine against Diarrheal Disease Caused by Campylobacter jejuni. Infect. Immun., 2009. 77(3): p. 1128-1136. 25. Cadoz Michel., Potential and limitations of polysaccharide vaccines in infancy. Vaccine, 1998. 16(14-15): p. 1391-1395. 26. Lee CJ., Bacterial capsular polysaccharides--biochemistry, immunity and vaccine. Molecular Immunology, 1987. 24(10): p. 1005-1019. 27. Lesinski GB and Westerink MA., Vaccines Against Polysaccharide Antigens. Curr Drug Targets Infect Disord, 2001. 1: p. 325-334. 28. Riottot MM, Fournier JM, and Jouin H., Direct evidence for the involvement of capsular polysaccharide in the immunoprotective activity of Klebsiella pneumoniae ribosomal preparations. Infect. Immun., 1981. 31(1): p. 71-77. 29. Oosterhuis-Kafeja F, Beutels P, and Van Damme P., Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006). Vaccine, 2007. 25(12): p. 2194-2212. 30. Chen YY, Yao SM, Chou CY, Chang YC, Shen PW, Huang CT, Su HP, and Li SY., Surveillance of invasive Streptococcus pneumoniae in Taiwan, 2002-2003. J Med Microbiol, 2006. 55(8): p. 1109-1114. 31. Bogaert D, Hermans PW, Adrian PV, Rümke HC, and de Groot R., Pneumococcal vaccines: an update on current strategies. Vaccine, 2004. 22(17-18): p. 2209-2220. 32. Hsu HE, Shutt KA, Moore MR, Beall BW, Bennett NM, Craig AS, Farley MM, Jorgensen JH, Lexau CA, Petit S, Reingold A, Schaffner W, Thomas A, Whitney CG, and Harrison LH., Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis. N Engl J Med, 2009. 360(3): p. 244-256. 33. Siber G.R., Pneumococcal disease: prospects for a new generation of vaccines. Science, 1994. 265(5177): p. 1385-1387. 34. Campbell WN, Hendrix E, Cryz S Jr, Cross AS., Immunogenicity of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered to victims of acute trauma. Clin Infect Dis., 1996. 23(1): p. 179-181. 35. Granström M, Wretlind B, Markman B, and Cryz S., Enzyme-linked immunosorbent assay to evaluate the immunogenicity of a polyvalent Klebsiella capsular polysaccharide vaccine in humans. J Clin Microbiol., 1988. 26(11): p. 2257–2261. 36. Edelman R, Taylor DN, Wasserman SS, McClain JB, Cross AS, Sadoff JC, Que JU, and Cryz SJ., Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneously. Vaccine, 1994. 12(14): p. 1288-1294. 37. Cryz SJ Jr, Fürer E, and Germanier R., Purification and vaccine potential of Klebsiella capsular polysaccharides. Infect. Immun., 1985. 50(1): p. 225-230. 38. Amako K, Meno Y, and Takade A., Fine structures of the capsules of Klebsiella pneumoniae and Escherichia coli K1. J. Bacteriol., 1988. 170(10): p. 4960-4962. 39. Bebrone C, Moali C, Mahy F, Rival S, Docquier JD, Rossolini GM, Fastrez J, Pratt RF, Frère JM, and Galleni M., CENTA as a chromogenic substrate for studying beta-lactamases. Antimicrob Agents Chemother. , 2001. 45(6): p. 1868-1871. 40. Gaston MA, Ayling-Smith BA, and Pitt TL., New bacteriophage typing scheme for subdivision of the frequent capsular serotypes of Klebsiella spp. J. Clin. Microbiol., 1987. 25(7): p. 1228-1232. 41. Pieroni, P., Thesis：Application of Bacteriophage Typing to Klebsiella pneumoniae. Saskatchewan University, Saskatchewan, Canada, 1996. 42. Sambrook J and Russell DW, Molecular Cloning: A Laboratory Manual (Third Edition). New York. CSHL, 2001. 43. Chang HC, Chen CR, Lin JW, Shen GH, Chang KM, Tseng YH, and Weng SF., Isolation and Characterization of Novel Giant Stenotrophomonas maltophilia Phage {phi}SMA5. Appl. Environ. Microbiol., 2005. 71(3): p. 1387-1393. 44. Briandet R, Lacroix-Gueu P, Renault M, Lecart S, Meylheuc T, Bidnenko E, Steenkeste K, Bellon-Fontaine MN, and Fontaine-Aupart MP., Fluorescence Correlation Spectroscopy To Study Diffusion and Reaction of Bacteriophages inside Biofilms. Appl. Environ. Microbiol., 2008. 74(7): p. 2135-2143. 45. Chibani-Chennoufi S, Dillmann ML, Marvin-Guy L, Rami-Shojaei S, and Brüssow H., Lactobacillus plantarum Bacteriophage LP65: a New Member of the SPO1-Like Genus of the Family Myoviridae. J. Bacteriol., 2004. 186(21): p. 7069-7083. 46. Qiagen, Qiagen Lambda Handbook. 1999. 47. Wu LT, Chang SY, Yen MR, Yang TC, and Tseng YH., Characterization of Extended-Host-Range Pseudo-T-Even Bacteriophage Kpp95 Isolated on Klebsiella pneumoniae. Appl. Environ. Microbiol., 2007. 73(8): p. 2532-2540. 48. Cortés G, Borrell N, de Astorza B, Gómez C, Sauleda J, and Albertí S., Molecular Analysis of the Contribution of the Capsular Polysaccharide and the Lipopolysaccharide O Side Chain to the Virulence of Klebsiella pneumoniae in a Murine Model of Pneumonia. Infect. Immun., 2002. 70(5): p. 2583-2590. 49. Favre-Bonté S, Licht TR, Forestier C, and Krogfelt KA., Klebsiella pneumoniae Capsule Expression Is Necessary for Colonization of Large Intestines of Streptomycin-Treated Mice. Infect. Immun., 1999. 67(11): p. 6152-6156. 50. Kabha K, Nissimov L, Athamna A, Keisari Y, Parolis H, Parolis LA, Grue RM, Schlepper-Schafer J, Ezekowitz AR, and Ohman DE, Relationships among capsular structure, phagocytosis, and mouse virulence in Klebsiella pneumoniae. Infect. Immun., 1995. 63(3): p. 847-852. 51. Shinefield HR, Black S, Ray P, Chang I, Lewis N, Fireman B, Hackell J, Paradiso PR, Siber G, Kohberger R, Madore DV, Malinowski FJ, Kimura A, Le C, Landaw I, Aguilar J, and Hansen J., Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. Pediatr Infect Dis J., 1999. 18(9): p. 757-763. 52. MacLean LL, Perry MB, and Vinogradov E., Characterization of the Antigenic Lipopolysaccharide O Chain and the Capsular Polysaccharide Produced by Actinobacillus pleuropneumoniae Serotype 13. Infect. Immun., 2004. 72(10): p. 5925-5930. 53. Lairini K., Stenbaek E, Lacouture S., and Gottschalk M., Production and characterization of monoclonal antibodies against Actinobacillus pleuropneumoniae serotype 1. Vet Microbiol, 1995. 46(4): p. 369-381. 54. Rahman MM, Guard-Petter J, Asokan K, Hughes C, and Carlson RW., The structure of the colony migration factor from pathogenic Proteus mirabilis. A capsular polysaccharide that facilitates swarming. J. Biol. Chem., 1999. 274(33): p. 22993-22998. 55. Lansing M.P., John P.H., and Donald A.K., Microbiology 2nd ed. William C Brown Pub, 1993. 56. Stephen MG. and Douwe v.S., Bacteriophage: Genetics and Molecular Biology. Caister Academic Press, 2007. 57. Ceyssens PJ, Lavigne R, Mattheus W, Chibeu A, Hertveldt K, Mast J, Robben J, and Volckaert G., Genomic Analysis of Pseudomonas aeruginosa Phages LKD16 and LKA1: Establishment of the ΦKMV Subgroup within the T7 Supergroup. J. Bacteriol., 2006. 188(19): p. 6924-6931. 58. Lavigne R, Noben JP, Hertveldt K, Ceyssens PJ, Briers Y, Dumont D, Roucourt B, Krylov VN, Mesyanzhinov VV, Robben J, and Volckaert G., The structural proteome of Pseudomonas aeruginosa bacteriophage phiKMV. Microbiology, 2006. 152(2): p. 529-534. 59. Haaber J, Moineau S, and Hammer K., Activation and Transfer of the Chromosomal Phage Resistance Mechanism AbiV in Lactococcus lactis. Appl. Environ. Microbiol., 2009. 75(10): p. 3358-3361. 60. Bayer ME, Thurow H, and Bayer MH., Penetration of the polysaccharide capsule of Escherichia coli (Bi161/42) by bacteriophage K29. Virology, 1979. 94(1): p. 95-118. 61. Geyer H, Himmelspach K, Kwiatkowski B, Schlecht S, and Stirm S., Degradation of bacterial surface carbohydrates by virus-associated enzymes. Pure Appl. Chem., 1983. 55(4): p. 637-653. 62. Hughes KA, Sutherland IW, Clark J, and Jones MV., Bacteriophage and associated polysaccharide depolymerases – novel tools for study of bacterial biofilms. J Appl Microbiol, 1998. 85(3): p. 583-590. 63. Pelkonen S, Aalto J, and Finne J., Differential activities of bacteriophage depolymerase on bacterial polysaccharide: binding is essential but degradation is inhibitory in phage infection of K1-defective Escherichia coli. J. Bacteriol., 1992. 174(23): p. 7757-7761. 64. Rodríguez C, Van der Meulen R, Vaningelgem F, Font de Valdez G, Raya R, De Vuyst L, and Mozzi F., Sensitivity of capsular-producing Streptococcus thermophilus strains to bacteriophage adsorption. Letters in Applied Microbiology, 2008. 46(4): p. 462-468. 65. Tomás JM, Camprubi S, Merino S, Davey MR, and Williams P., Surface exposure of O1 serotype lipopolysaccharide in Klebsiella pneumoniae strains expressing different K antigens. Infect. Immun., 1991. 59(6): p. 2006-2011. 66. Rieger-Hug D and Stirm S., Comparative study of host capsule depolymerases associated with Klebsiella bacteriophages. Virology, 1981. 113(1): p. 363-378. 67. Chhibber S, Kaur S, and Kumari S., Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice. J Med Microbiol, 2008. 57(12): p. 1508-1513. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/43045 | - |
| dc.description.abstract | 過去二十年來，在台灣陸續出現新型侵襲性克雷伯氏肺炎桿菌病例。此菌會造成原發性肝膿瘍、敗血性休克、菌血症、轉移性眼內炎、腦膜炎等嚴重病徵。克雷伯氏肺炎桿菌菌體最外層的莢膜與其黏附、毒性有極大關聯，特別是毒性較強的K1和K2莢膜血清型菌株。施打疫苗是疾病預防重要策略之一。市售肺炎鏈球菌疫苗即為複數種莢膜多醣寡分子（capsular polysaccharide oligomers）混合成多效價疫苗。故尋找能夠切割巨大莢膜成小分子，又不影響其免疫原特性之方法是我們努力的目標。已有研究指出噬菌體能對莢膜多醣產生切割降解效果（CPS depolymerization）。因此，在本研究中，我們收取未經處理的原水與克雷伯氏肺炎桿菌K1莢膜血清型菌株NTUH-K2044共同培養，分離出能夠感染此菌株之18個噬菌體候選。經噬菌體純化、DNA萃取與限制性核酸內切酶（EcoRI、HindIII與PstI）剪切反應，得知這些噬菌體均為雙股DNA噬菌體，再由其相同限制性片段長度多態性（restriction fragment length polymorphism, RFLP）判別為相同噬菌體，並依據片段大小預估其基因組大小約為40Kbp。取噬菌體DNA片段序列與NCBI BLAST資料庫裡的DNA與胺基酸序列做比對，推斷為一全新未知噬菌體，且屬於ΦKMV噬菌體群一員。此外，使用穿透式電子顯微鏡（TEM）可觀察到此噬菌體型態。透過塗點試驗（Spot test）進行此噬菌體宿主範圍分析，發現其對感染克雷伯氏肺炎桿菌K1莢膜血清型菌株具有專一性。目前已完成於噬菌體DNA大片段定序（42.5 Kbp），與進行莢膜多醣降解實驗，結果顯示莢膜多醣可能降解成以數個單醣鏈結之分子存在。在未來，此噬菌體將有機會應用於菌種或菌株之鑑定，以及複合疫苗發展。 | zh_TW |
| dc.description.abstract | Klebsiella pneumoniae caused community-acquired pyogenic liver abscess is an emerging infectious disease and is often complicated with metastatic endophthalmitis and septic meningitis. Capsular serotypes, especially K1 and K2, were reported to play an important role in pathogenesis of K. pneumoniae causing pyogenic liver abscess. In this study, bacteriophages were isolated from the co-culture of serotype K1 K. pneumoniae NTUH-K2044 strain and sewage. We randomly selected eighteen bacteriophages for further study. By experiments of restriction enzyme digestion, we have known that the genome of bacteriophages were double-stranded DNA and the length of restriction fragments among these eighteen bacteriophages were identical. The genome size of bacteriophage was predicted to be about 40 kbp, and a rough morphology of bacteriophage was observed by transmission electron microscope. Our preliminary result revealed that the sequences of this bacteriophage was novel by comparison with NCBI BLAST databases, and we had a DNA frament covering about 95% area of bacteriophage genome. With spot test for host range, we found the new bacteriophage specifically infected K. pneumoniae serotype K1. In addition, it’s been known that capsular polysaccharide degraded to oligomers after phage treatment could be detected by Western blotting and mass spectrometry. This bacteriophage might be a good candidate for typing, and helps the development of conjugate vaccine. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T01:34:18Z (GMT). No. of bitstreams: 1 ntu-98-R96445127-1.pdf: 6232512 bytes, checksum: 0fde840b7b3fe0baedbef3b2a71ce8ab (MD5) Previous issue date: 2009 | en |
| dc.description.tableofcontents | 圖目錄..................................................................................................... 3
表目錄..................................................................................................... 4 中文摘要................................................................................................. 5 英文摘要................................................................................................. 6 第一章、 緒論........................................................................................ 7 第二章、 材料與方法.......................................................................... 11 1. 實驗菌株........................................................................................... 11 2. 質體及培養基.................................................................................... 11 3. 尋找及分離噬菌體............................................................................ 11 4. 塗點試驗............................................................................................ 13 5. 噬菌體增生........................................................................................ 13 6. 噬菌體純化與DNA萃取.................................................................... 14 7. 限制性核酸內切酶實驗.................................................................... 15 8. 噬菌體DNA選殖................................................................................ 16 9. 噬菌體基因體序列分析.................................................................... 17 10. 噬菌體溶菌斑效價分析.................................................................. 18 11. 穿透式電子顯微鏡觀察噬菌體型態.............................................. 18 12. 莢膜多醣抽取法.............................................................................. 19 13. 莢膜多醣與噬菌體交互反應實驗.................................................. 19 14. 十二烷基硫酸鈉膠凝體電泳與西方轉漬...................................... 20 15. 噬菌體對莢膜多醣剪切分析.......................................................... 22 第三章、 實驗結果................................................................................23 1. 尋找及分離噬菌體與塗點試驗........................................................ 23 2. 挑選對克雷伯氏肺炎桿菌菌株NTUH-K2044（K1）具感染能力之噬菌體..................................................................................... 23 3. K1噬菌體生物資訊分析與基因體定序........................................... 24 4. K1噬菌體溶菌斑效價分析.............................................................. 25 5. 穿透式電子顯微鏡TEM觀察K1噬菌體型態.................................. 25 6. K1噬菌體宿主範圍分析與對克雷伯氏肺炎桿菌K1莢膜型不同菌株之感染能力............................................................................. 25 7. 克雷伯氏肺炎桿菌菌株NTUH-K2044衍生突變株對K1噬菌體感染之敏感度.................................................................................... 26 8. K1噬菌體對克雷伯氏肺炎桿菌菌株NTUH-K2044（K1）莢膜多醣之剪切效果............................................................................... 27 第四章、 總結與討論........................................................................ 28 第五章、 參考文獻............................................................................ 49 | |
| dc.language.iso | zh-TW | |
| dc.title | 水中分離之克雷伯氏肺炎桿菌噬菌體特性分析 | zh_TW |
| dc.title | Isolation and Characterization of a Bacteriophage of Klebsiella pneumoniae from Water | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 97-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 鄧麗珍,董馨蓮 | |
| dc.subject.keyword | 克雷伯氏肺炎桿菌,莢膜多醣,噬菌體, | zh_TW |
| dc.subject.keyword | Klebsiella pneumoniae,capsular polysaccharides,bacteriophage, | en |
| dc.relation.page | 53 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2009-07-20 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 微生物學研究所 | zh_TW |
| 顯示於系所單位： | 微生物學科所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-98-1.pdf 目前未授權公開取用 | 6.09 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。